ClinicalTrials.Veeva

Menu

Hyaluronic Acid Gel in Ridge Preservation

A

Ain Shams University

Status and phase

Completed
Phase 4

Conditions

Hyaluronic Acid Gel for Preservation the Extraction Socket

Treatments

Drug: Hyaluronic acid
Other: empty socket

Study type

Interventional

Funder types

Other

Identifiers

NCT06176937
FD-ASU-REC.852

Details and patient eligibility

About

hyaluronic acid gel applied at the extraction socket after extraction immediately to preserve the socket from post extraction resorption. hyaluronic acid has ability for osteogenesis and new bone formation.

Full description

twenty-four patients with one hopeless tooth at least, first CBCt before extraction to evaluate the dimension of the socket, then atraumatic extraction of the tooth to preserve the bony wall of the socket, after extraction and curettage the socket applied hyaluronic acid gel inside the socket and applied collagen membrane to secure the socket. After 4 months of extraction, CBCt was done to evaluate the dimension of the socket and the effect of hyaluronic acid. Furthermore, The core biopsy was taken by trephine bur at the time of implant placement for evaluate the histological appearance of the bone to evaluate the secondary outcome. then after three months the crown was delivered as a prosthetic part.

Enrollment

24 patients

Sex

All

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Healthy adult patients as evidenced by Burkett's oral medicine health history questionnaire

  2. Both genders.

  3. Age from 20 -50 years old.

  4. Having at least one hopeless teeth indicated for extraction.

  5. Esthetic zone teeth (anterior or premolar).

  6. Sockets type 1 or 2 .

  7. Patient should agree to sign a written consent after the nature of the study will be explained.

    Exclusion Criteria:

1- Smokers. 2- Pregnant and breast-feeding females. 3- Mentally retarded Patients. 4- Prisoners and handicapped patients. 5- Patients with malocclusion.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

24 participants in 2 patient groups

hyaluronic acid gel
Active Comparator group
Description:
Hyaluronic acid considers as a high molecular weight glycosaminoglycan (GAG) consists of multiple disaccharide non-sulfated units of D-glucuronic acid and N-acetylglucosamine
Treatment:
Drug: Hyaluronic acid
empty socket
Other group
Description:
extraction socket without application any drug
Treatment:
Other: empty socket

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems